🔥Telegram İfşa

The ACL SNNAP trial, led by researchers from NDORMS, has found that going straight to reconstructive surgery has a better outcome than undergoing rehabilitation first for anterior cruciate ligament injury. ndorms.ox.ac.uk/news/ACL-SSNAP…

Immediate surgical reconstruction of the ACL in patients with symptomatic non-acute injury is a superior management strategy when compared with rehabilitation, a new trial suggests. hubs.li/Q01kJkz-0

Here's . at the Nordic Workshop on Bibliometrics & Research Policy (NWB2022) in Finland! Digital Science (Digital Science) is a proud sponsor of #NWB2022 and you can find us at the event from 21-23 Sept. Dimensions

At the start of #nwb2022, . discusses international collaboration and protection of research from foreign interference. Together with Russia and Hong Kong, Brazil is listed as a country with declining academic freedom. Less collaboration opportunities result from that.

Great presentation with some strong messages from @MiedemaF in #nwb2022.

Great time in #Melbourne at the #DSAPAC2023. Had the honour to: - give an update and roadmap on Altmetric - discuss the potential future of impact metrics - do an interactive session on #SDGs analysis Also learnt a lot about Figshare, Symplectic and Dimensions! Amazing!

Indeed, we could easily talk about it for the rest of the day! Thank you Garth and MAPS for the opportunity to talk a bit about our ongoing work!

Amazing to see this important piece of work on the clinical characterisation of #prostatecancer patients undergoing conservative management published. It was an epic effort that started in a Prostate PIONEER , OHDSI and EHDEN study-a-thon! Congrats to everyone involved!!!

How can #AI help tell us who's talking about your research & what they're saying? Find out more about Share of Voice in this MAPS podcast with Mike Taylor & Carlos Areia: ow.ly/NqhH50PckKm Altmetric Dimensions #AIAppreciationDay #ArtificialIntelligence

PhDone! I would like to thank everyone involved for all the help, patience and support! Dr Sarah Vollam NIHR Oxford Biomedical Research Centre OxCritCareResearch Chartered Society of Physiotherapy (CSP) Mike Taylor Coventry University Now on to new challenges :)

After a few years of work and revisions I am very pleased to see our Cochrane review published! Massive congratulations to the team and thanks to the The Cochrane Library team for all the help and support :) cochranelibrary.com/cdsr/doi/10.10…

Had an amazing time in Gothenburg! I always learn so much at the Nordic Workshops! Thanks for having me again :)

📢 New webinar: "Tracking multiple languages in the Altmetric Explorer". Find out how different languages contribute a unique voice to the representation of #research & #trust. 🗓️ Tues 31 Oct Register now: ow.ly/624C50Q09ls Mike Taylor Carlos Areia #Wikipedia #Altmetrics

Delighted that our paper investigating the use of an ambulatory monitoring system to support patient safety during the covid pandemic has been published! Huge thanks to Dr Sarah Vollam Carlos Areia Cristian Roman OxCritCareResearch for the support! onlinelibrary.wiley.com/share/RBSIYGQI…

Are the changes at X affecting research discourse on the platform? If so, how? In our latest blog, prepared in collaboration with Digital Science's Carlos Areia & Mike Taylor, we dig into the numbers to answer these questions: altmetric.com/blog/since-twi…

Next up at #RLUK24: Roundtable session with 🎙️Chris Banks (she/her) Prof Catherine Davies rachelbruce Jim Grange Dr Elizabeth Gadd @lizziegadd.bsky.social discussing how we can build an open & transparent research culture.

#rluk24 watch party here at Open Research, University of Aberdeen 'moving from gatekeepers to facilitators of knowledge'Carlos Areia

Ground breaking study that continues to show that using celebrities as case studies and subjects boosts public engagement with research Carlos Areia taylorfrancis.com/chapters/edit/…

Two weeks ago, Carrie Brubaker, Carlos Areia recorded a pod for MAPS about 'interesting' research in the pharma space. I picked 2 articles about TB, which kills millions. A new drug nature.com/articles/s4159… and APOPO medicalaffairs.org/top-10-most-in…

Ever considered a PhD by Publication?